AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
How to Build and Sell a Biotech in 2024
Strategic Alternatives
Investor Priorities in Biotech Acquisitions
Exploring the focus of investors on de-risked assets with high upside potential in biotech companies, emphasizing aspects like market timeline, revenue generation, and asset value. The episode wraps up by inviting listeners to connect with RBC Capital Markets for more insights and discussions.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode